M. Brunet

Feasibility of the AML profiler (Skyline™ Array) for patient risk stratification in a multicentre trial: a preliminary comparison with the conventional approach

F. Solé, M. Tormo, A. Aventín, 2017, Hematological oncology.

Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.

J. Sierra, J. Besalduch, J. Pérez-Simón, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.